Home    Back

 Drug    DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, Adalimumab

ABCDEFGH I JKLMNOPQRSTUVWXYZother

25 / 17,542 descriptions

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 Disease ID
 1  4.5 mg naltrexone  Naltrexone  [2] D02095, D05113 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 2  Low dose naltrexone  Naltrexone  [2] D02095, D05113 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [2] 96, 97 💬 
 3  Low-dose naltrexone  Naltrexone  [2] D02095, D05113 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 4  Nal  -  -  -  -  [2]  6 , 299 💬 
 5  Nalbuphine  Nalbuphine  [2] D00843, D08246 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 85 💬 
 6  Nalbuphine er  Nalbuphine  [2] D00843, D08246 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 85 💬 
 7  Nalbuphine extended-realease (er) tablets  Nalbuphine  [2] D00843, D08246 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 85 💬 
 8  Nalbuphine extended-release (er) tablets  Nalbuphine  [2] D00843, D08246 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 85 💬 
 9  Nalbuphine hydrochloride  Nalbuphine  [2] D00843, D08246 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 85 💬 
 10  Nalmefene  Nalmefene  [1] D05111 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 11  Naloxone  Naloxone  [2] D01340, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [2]  6 , 226 💬 
 12  Naloxone hydrochloride  Naloxone  [2] D01340, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 13  Naloxone hydrochloride dihydrate  Naloxone  [2] D01340, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 14  Naltrexone  Naltrexone  [2] D02095, D05113 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [12]  6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 
 15  Naltrexone hydrochloride  Naltrexone  [2] D02095, D05113 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [8] 10, 40, 41, 42, 43, 44, 45, 96 💬 
 16  Naltrexone-hcl  Naltrexone  [2] D02095, D05113 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 96 💬 
 17  Oxycodone naloxone prolonged release tablets  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 18  Oxycodone/naloxone prolonged release t  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 19  Oxycodone/naloxone prolonged release tablets  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 20  Oxycodone/naloxone prolonged release tablets 10 mg /5 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 21  Oxycodone/naloxone prolonged release tablets 10/5 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 22  Oxycodone/naloxone prolonged release tablets 20 mg /10 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 23  Oxycodone/naloxone prolonged release tablets 20/10 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 24  Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 25  Oxycodone/naloxone prolonged release tablets 5/2.5 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 

Back to top